According to the results of a study, where the COVID-specific T-cell response was studied two weeks after the second BNT162b2 vaccination dose, RA patients receiving TNF-α inhibitors and IL-6 inhibitor had substantially impaired COVID-specific T-cell response than that of the controls’ (21). Here, IL6 is linked to rheumatoid arthritis.